WEIGHTED AVERAGE CALCULATIONS FOR POPULATING COST-EFFECTIVENESS MODELS: HOW IGNORING THE MODEL'S CLINICAL PATHWAYS CAN SIGNIFICANTLY BIAS THE INCREMENTAL COST-EFFECTIVENESS RATIO

被引：0

作者：

Van Vlaenderen, I ^{[1
]}

Moeremans, K. ^{[1
]}

Van Bellinghen, L. ^{[1
]}

机构：

[1] CHESS Hlth, Bonheiden, Belgium

来源：

VALUE IN HEALTH | 2018年 / 21卷

关键词：

D O I：

10.1016/j.jval.2018.09.030

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

CP4

引用

页码：S5 / S6

页数：2

共 50 条

[31] Aggregating cost data from multicenter clinical trials: An incremental cost-effectiveness elasticity approach
Tano, BD
Stanford, RH
Pathak, DS
VALUE IN HEALTH, 2004, 7 (03) : 303 - 303
[32] How can the quality and cost-effectiveness of a work rehabilitation process be improved?
Gard, G
Larsson, A
INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2004, 39 (5-6) : 506 - 506
[33] COST-EFFECTIVENESS: HOW CAN WE USE WHAT WE KNOW?
El-Kour, Tatyana
ANNALS OF NUTRITION AND METABOLISM, 2017, 71 : 221 - 222
[34] HOW COST-EFFECTIVENESS OF COMPARATORS ARE RANKED: CASE IN SCHIZOPHRENIA ECONOMIC MODELS
Zhou, J.
Millier, A.
Toumi, M.
VALUE IN HEALTH, 2018, 21 : S99 - S99
[35] A cost-effectiveness clinical decision analysis model for treatment of schizophrenia
Palmer, CS
Brunner, E
Ruíz-Flores, LG
Paez-Agraz, F
Revicki, DA
ARCHIVES OF MEDICAL RESEARCH, 2002, 33 (06) : 572 - 580
[36] The results of a pharmacoeconomic study: incremental cost-effectiveness ratio versus net monetary benefit
Messori, Andrea
Trippoli, Sabrina
HEART, 2017, 103 (21) : 1746 - 1746
[37] MULTIPLE DECISION CRITERIA FOR ASSESSING AN INCREMENTAL COST-EFFECTIVENESS RATIO OF EXPENSIVE HEALTH TECHNOLOGIES
Kamae, I
Yamabe, K.
Sugimoto, T.
VALUE IN HEALTH, 2014, 17 (07) : A586 - A586
[38] IMPROVED BOOTSTRAP POINT AND CONFIDENCE INTERVAL ESTIMATION OF THE INCREMENTAL COST-EFFECTIVENESS RATIO (ICER)
Skrepnek, G. H.
Sahai, A.
VALUE IN HEALTH, 2014, 17 (03) : A201 - A201
[39] A simulation study to compare methods for constructing confidence intervals for the incremental cost-effectiveness ratio
Fan M.-Y.
Zhou X.-H.
Health Services and Outcomes Research Methodology, 2007, 7 (1-2) : 57 - 77
[40] Incremental Cost-Effectiveness Ratio of Alteplase in Patients with Acute Myocardial Infarction in the French Setting
Alain Pelc
Jacques Dardenne
Jean-Hughes Frelon
Guy Hanania
PharmacoEconomics, 1997, 11 : 595 - 605

← 1 2 3 4 5 →